Cannabis Science Provides Growth Guidance on its Medicine Dispensing Systems (MDS) Exclusive & Non-Exclusive Agreements

CBIS Sees Canada as Flagship Market Launch COLORADO SPRINGS, Colo. — (NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis-based pharmaceutical development and related consulting operations, provides shareholder clarity and growth guidance for its gross profit sharing exclusive and non-exclusive agreement in select markets with MDS, a subsidiary of Medbox, Inc. Under […]

Read More

Cannabis Science (CBIS) Moves Forward with Critical Support of Landmark Federal Cannabis Legislative Initiative

COLORADO SPRINGS, Colo.— (CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development, is a key leader in the private sector challenge to end the restrictions on cannabis drug development and research in the U.S. “The Cannabinoid Scientific Research and Development Act,” which will be submitted for congressional review in the U.S. […]

Read More

New York Doctors Say Bloomberg’s Statement on Medical Marijuana is Outrageous & Flies In the Face of Medical Science

<p>Mayor&rsquo;s Claim that Medical Marijuana is &ldquo;Hoax&rdquo; Comes One Day after 600 New York Physicians Pledge Support for NY Medical Marijuana Bill</p> New York – Mayor Bloomberg ran afoul of medical science and the opinions of more than 600 New York physicians when he called medical marijuana “one the great hoaxes of all time” earlier […]

Read More